Sort   by:  
 Page size 
UnknownCrucial roles of circulating tumor cells in the metastatic cascade and tumor immune escape: biology and clinical translation.
Not available
S-EPMC9756199 | biostudies-literature
UnknownDetection of Androgen Receptor Variant 7 (ARV7) mRNA Levels in EpCAM-Enriched CTC Fractions for Monitoring Response to Androgen Targeting Therapies in Prostate Cancer.
Not available
S-EPMC6770695 | biostudies-literature
UnknownAnalysis of Circulating Tumor Cells in Patients with Non-Metastatic High-Risk Prostate Cancer before and after Radiotherapy Using Three Different Enumeration Assays.
Not available
S-EPMC6627099 | biostudies-literature
UnknownHigh Sensitivity of Circulating Tumor Cells Derived from a Colorectal Cancer Patient for Dual Inhibition with AKT and mTOR Inhibitors.
Not available
S-EPMC7566012 | biostudies-literature
UnknownFunctional analysis of circulating tumour cells: the KEY to understand the biology of the metastatic cascade.
Not available
S-EPMC9427839 | biostudies-literature
UnknownAutologous cell lines from circulating colon cancer cells captured from sequential liquid biopsies as model to study therapy-driven tumor changes.
Not available
S-EPMC6206091 | biostudies-literature
UnknownCirculating Tumor Cells as a Marker of Disseminated Disease in Patients with Newly Diagnosed High-Risk Prostate Cancer.
Not available
S-EPMC7017349 | biostudies-literature
UnknownAnalysis of the Plasticity of Circulating Tumor Cells Reveals Differentially Regulated Kinases During the Suspension-to-Adherent Transition.
Not available
S-EPMC11489281 | biostudies-literature
ProteomicsTargeting the AKT/mTOR pathway attenuates the metastatic potential of colorectal carcinoma circulating tumor cells in a murine xenotransplantation model
Circulating tumor cells (CTCs) play an important role in metastasis formation. Aberrant signaling of oncogenic pathways (e.g. PI3K/AKT/mTOR pathway) drives tumor progression. In this work, the susceptibility of the colon cancer CTC derived cell line, CTC-MCC-41, for AKT and mTOR inhibitors was evalu...
ORGANISM(S): Homo sapiens (Human) 
2025-04-14 | PXD054001 | Pride
Ctcs  pi3k/akt/mtor pathway  akt isoforms  xenotransplantation model  proteomics  mk2206  rad001  colorectal carcinoma  drug sensitivity assays  dual targeting  personalized medicine  targeted therapy 
UnknownTargeting the AKT/mTOR pathway attenuates the metastatic potential of colorectal carcinoma circulating tumor cells in a murine xenotransplantation model.
Not available
S-EPMC12515692 | biostudies-literature
Sort   by:  
 Page size